RWS Targets CNS Trial Data Variability with New Rater Training Service

Event summary

  • RWS launched a CNS rater training, certification, and retraining service on February 2, 2026 to improve data quality in clinical trials.
  • The service addresses variability in rater assessments, a key risk in CNS studies that can affect trial outcomes.
  • Features include qualification reviews, customized training, digital certification, and centralized tracking.
  • The service supports global, decentralized trials and integrates with any eCOA platform.

The big picture

As CNS trials become more global and decentralized, ensuring rater consistency has become critical. RWS’s new service directly addresses this challenge by combining specialized training with digital workflows, positioning itself as a key player in the clinical trial data integrity space. The move reflects broader industry trends toward AI-driven solutions for improving trial efficiency and reliability.

What we're watching

Adoption Pace
How quickly pharmaceutical sponsors and CROs will integrate RWS’s service into their CNS trial workflows.
Competitive Response
Whether existing competitors will enhance their own rater training offerings to match RWS’s specialized approach.
Regulatory Alignment
The extent to which RWS’s service will be recognized as meeting evolving regulatory expectations for CNS trial data consistency.

Related topics

Clinical Trials